Concepts in glioma immunotherapy
Immunotherapeutic concepts in neurooncology have been developed for many decades but have mainly been hampered by poor definition of relevant antigens and selective measures to target the central nervous system. Independent of the recent remarkable successes in clinical immunooncology with checkpoin...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
26 July 2016
|
| In: |
Cancer immunology immunotherapy
Year: 2016, Jahrgang: 65, Heft: 10, Pages: 1269-1275 |
| ISSN: | 1432-0851 |
| DOI: | 10.1007/s00262-016-1874-x |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00262-016-1874-x Verlag, Volltext: https://link.springer.com/article/10.1007/s00262-016-1874-x 
|
| Verfasserangaben: | Michael Platten, Lukas Bunse, Wolfgang Wick, Theresa Bunse |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1565617991 | ||
| 003 | DE-627 | ||
| 005 | 20220814030033.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171122s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00262-016-1874-x |2 doi | |
| 035 | |a (DE-627)1565617991 | ||
| 035 | |a (DE-576)495617997 | ||
| 035 | |a (DE-599)BSZ495617997 | ||
| 035 | |a (OCoLC)1340982397 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 245 | 1 | 0 | |a Concepts in glioma immunotherapy |c Michael Platten, Lukas Bunse, Wolfgang Wick, Theresa Bunse |
| 264 | 1 | |c 26 July 2016 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.11.2017 | ||
| 520 | |a Immunotherapeutic concepts in neurooncology have been developed for many decades but have mainly been hampered by poor definition of relevant antigens and selective measures to target the central nervous system. Independent of the recent remarkable successes in clinical immunooncology with checkpoint inhibitors and vaccines, immunotherapy of brain tumors in general and gliomas in particular has evolved with novel neurooncology-specific concepts over the past years providing new phase 1 approaches of individualized immunotherapy to first phase three clinical trials. These concepts are driven by a high medical need in the absence of approved targeted therapies and refute the classic dogma that the central nervous system is immune-privileged and hence inaccessible to potent antitumor immunity. Instead, measures have been taken to improve the odds for successful immunotherapies, including rational targeting of relevant antigens and integration of immunotherapies into standard of care primary radiochemotherapy to increase the efficacy of antitumor immunity in a meaningful time window. This review highlights concepts and challenges associated with epitope discovery and selection and trial design. | ||
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer immunology immunotherapy |d Berlin : Springer, 1976 |g 65(2016), 10, Seite 1269-1275 |h Online-Ressource |w (DE-627)253390443 |w (DE-600)1458489-X |w (DE-576)072283475 |x 1432-0851 |7 nnas |a Concepts in glioma immunotherapy |
| 773 | 1 | 8 | |g volume:65 |g year:2016 |g number:10 |g pages:1269-1275 |g extent:7 |a Concepts in glioma immunotherapy |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00262-016-1874-x |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00262-016-1874-x |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20171122 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 3 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 910000 |d 911100 |e 910000PP121627780 |e 911100PP121627780 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1565617991 |e 2987949022 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1565617991"],"doi":["10.1007/s00262-016-1874-x"]},"name":{"displayForm":["Michael Platten, Lukas Bunse, Wolfgang Wick, Theresa Bunse"]},"recId":"1565617991","physDesc":[{"extent":"7 S."}],"title":[{"title_sort":"Concepts in glioma immunotherapy","title":"Concepts in glioma immunotherapy"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.11.2017"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"26 July 2016"}],"person":[{"display":"Platten, Michael","family":"Platten","given":"Michael","role":"aut"},{"display":"Wick, Wolfgang","family":"Wick","given":"Wolfgang","role":"aut"}],"relHost":[{"id":{"eki":["253390443"],"issn":["1432-0851"],"zdb":["1458489-X"]},"part":{"volume":"65","year":"2016","issue":"10","text":"65(2016), 10, Seite 1269-1275","extent":"7","pages":"1269-1275"},"titleAlt":[{"title":"CII"}],"pubHistory":["1.1976 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 15.05.2024","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 52.2003: Supplement"],"title":[{"title_sort":"Cancer immunology immunotherapy","title":"Cancer immunology immunotherapy","subtitle":"CII"}],"origin":[{"publisher":"Springer","publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1976","dateIssuedDisp":"1976-"}],"disp":"Concepts in glioma immunotherapyCancer immunology immunotherapy","physDesc":[{"extent":"Online-Ressource"}],"recId":"253390443"}]} | ||
| SRT | |a PLATTENMICCONCEPTSIN2620 | ||